Back

Title
  • en The effect of antagonism of adenosine A1 receptor against ischemia and reperfusion injury of the liver
Creator
    • en Magata, Shinichiro
    • en Taniguchi, Masahiko
    • en Suzuki, Tomomi
    • en Shimamura, Tsuyoshi
    • en Fukai, Moto
    • en Furukawa, Hiroyuki
    • en Fujita, Miri
Accessrights open access
Subject
  • Other en liver
  • Other en ischemia and reperfusion injury
  • Other en adenosine
  • Other en adenosine A1 receptor antagonist
  • Other en KW3902
  • Other en dog
  • NDC 464.657
Description
  • Abstract en Background: Adenosine is known to exert protective roles in hepatic ischemia and reperfusion injury, while all adenosine receptors do not play the cytoprotective roles. We have tested our hypothesis that blockage of adenosine binding to A1 receptor by its antagonist, KW3902 [8-(noradamantan-3-yl)-1,3-dipropylxanthine] attenuates hepatic ischemia-reperfusion injury. Methods: Adult female beagle dogs underwent a 2 h total hepatic vascular exclusion (THVE) with a venovenous bypass. Nontreated animals that underwent THVE with a venovenous bypass alone were used as the control (Group CT, n = 6). KW3902 was given to the animals by continuous intraportal infusion for 60 min before ischemia at a dose of 1μg/kg/min (Group KW, n = 6). Two wk survival, hemodynamics, hepatic tissue blood flow (HTBF), liver function, energy metabolism, cAMP concentration, and histopathological findings were studied. Results: Two wk animal survival was significantly improved in group KW compared with that in group CT (group CT: 16.7% versus group KW: 83.3%). HTBF, liver function, and hepatic adenine nucleotide concentration were remarkably better in group KW than group CT. In addition, cAMP concentration in group KW was maintained significantly higher than group CT. Histopathological examination revealed preservation of hepatic architecture and suppression of neutrophil infiltration into hepatic tissue in group KW. Conclusion: Administration of adenosine A1 receptor antagonist before ischemia attenuates hepatic ischemia-reperfusion injury. To elicit the beneficial effect of adenosine against ischemia and reperfusion injury of the liver, it is important to oppose adenosine A1 receptor activation.
Publisher en Elsevier
Date
    Issued2007-05-01
Language
  • eng
Resource Type journal article
Version Type AM
Identifier HDL http://hdl.handle.net/2115/22558
Relation
  • URI http://www.sciencedirect.com/science/journal/00224804
  • isVersionOf DOI https://doi.org/10.1016/j.jss.2006.09.021
  • PMID 17336335
Journal
    • PISSN 0022-4804
    • EISSN 1095-8673
      • en Journal of Surgical Research
      • Volume Number139 Issue Number1 Page Start7 Page End14
File
    • fulltext JSR139-1.pdf
    • 418.49 KB (application/pdf)
      • Issued2007-05-01
Oaidate 2023-07-26